IP Library › Granted Patent US 11,419,976
Granted Patent B1
US 11,419,976 · App. 17/246,198 · Granted Aug 23, 2022

Wearable drug delivery device with pressurized fluid dispensing

Inventors: David R. Schiff (Highland Park, NJ); Sharon D. West (Elkins Park, PA)
Assignee: Fresenius Kabi Deutschland GmbH
A61M5/14248A61M5/1452A61M5/16881A61M2005/14252A61M2202/0007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,419,976
App. No.
17/246,198
Granted
Aug 23, 2022
Kind
B1
Abstract

A drug delivery device has a housing with an adhesive pad associated with the lower surface of the housing and configured to removably attach to a human body surface. A drug reservoir is positioned within the housing and includes an outlet with a valve, with a needle fluidically connected to the reservoir and configured to define at least a portion of a fluid flow path between the reservoir and the human body surface. A controller is configured to control the components of the drug delivery device to execute a drug delivery routine. The drug delivery device also includes pressurized fluid positioned to apply a force to the reservoir. The controller moves the valve from a closed condition to an open condition during a drug delivery routine to allow the pressurized fluid to deform the reservoir or move a plunger to convey the drug out of the reservoir via the outlet.

Claims (39)

1. A drug delivery device comprising:

a housing;

an adhesive pad associated with a lower surface of the housing and configured to removably attach to a human body surface;

a deformable drug reservoir positioned within the housing and including an outlet with a valve;

a needle fluidically connected to the outlet of the drug reservoir and configured to define at least a portion of a fluid flow path between the drug reservoir and said human body surface;

a controller configured to execute a drug delivery routine; and

a pressurized fluid positioned between the housing and the drug reservoir in a space defined in part by the drug reservoir, with the pressurized fluid exerting a compressive force on the drug reservoir, wherein the controller is configured to control the valve to move from a closed condition to an open condition during said drug delivery routine so as to allow the pressurized fluid to deform the drug reservoir, thereby conveying a drug out of the drug reservoir via the outlet.

2. The drug delivery device of claim 1 , configured to deliver a drug comprising pegfilgrastim.

3. The drug delivery device of claim 1 , wherein the controller is configured to control the valve to move from the closed condition to the open condition a single time and remain open during the drug delivery routine.

4. The drug delivery device of claim 1 , wherein the controller is further configured to control the valve to move from the open condition to the closed condition to prevent further removal of the drug from the drug reservoir.

5. The drug delivery device of claim 4 , wherein the controller is configured to move the valve from the open condition to the closed condition when a predetermined amount of the drug is conveyed from the drug reservoir.

6. The drug delivery device of claim 4 , wherein the controller is configured to move the valve from the open condition to the closed condition a predetermined amount of time after moving the valve from the closed condition to the open condition.

7. The drug delivery device of claim 1 , wherein the controller is configured to control the valve to move between the closed condition and the open condition a plurality of times during the drug delivery routine.

8. The drug delivery device of claim 7 , wherein the controller is configured to control the valve to move between the closed condition and the open condition in a regular pattern.

9. The drug delivery device of claim 8 , wherein the pattern is a duty cycle.

10. The drug delivery device of claim 1 , wherein

at least a portion of the outlet is deformable, and

the valve comprises a pinch valve configured to engage and deform the outlet in the closed condition.

11. A drug delivery device comprising:

a housing;

an adhesive pad associated with a lower surface of the housing and configured to removably attach to a human body surface;

a drug reservoir positioned within the housing and including an outlet with a valve;

a plunger positioned within the drug reservoir, separating an interior of the drug reservoir into first and second chambers;

a needle fluidically connected to the outlet of the drug reservoir and configured to define at least a portion of a fluid flow path between the drug reservoir and said human body surface;

a controller configured to execute a drug delivery routine; and

a pressurized fluid sealed within the first chamber of the drug reservoir and exerting a force on the plunger, wherein

the amount of pressurized fluid in the first chamber is constant throughout the drug delivery routine, and

the controller is configured to control the valve to move from a closed condition to an open condition during said drug delivery routine so as to allow the pressurized fluid to move the plunger toward the outlet, thereby conveying a drug positioned within the second chamber out of the drug reservoir via the outlet.

12. The drug delivery device of claim 11 , configured to deliver a drug comprising pegfilgrastim.

13. The drug delivery device of claim 11 , wherein the controller is configured to control the valve to move from the closed condition to the open condition a single time and remain open during the drug delivery routine.

14. The drug delivery device of claim 11 , wherein the controller is further configured to control the valve to move from the open condition to the closed condition to prevent further removal of the drug from the drug reservoir.

15. The drug delivery device of claim 14 , wherein the controller is configured to move the valve from the open condition to the closed condition when a predetermined amount of the drug is conveyed from the drug reservoir.

16. The drug delivery device of claim 14 , wherein the controller is configured to move the valve from the open condition to the closed condition a predetermined amount of time after moving the valve from the closed condition to the open condition.

17. The drug delivery device of claim 11 , wherein the controller is configured to control the valve to move between the closed condition and the open condition a plurality of times during the drug delivery routine.

18. The drug delivery device of claim 17 , wherein the controller is configured to control the valve to move between the closed condition and the open condition in a regular pattern.

19. The drug delivery device of claim 18 , wherein the pattern is a duty cycle.

20. The drug delivery device of claim 11 , wherein

at least a portion of the outlet is deformable, and

the valve comprises a pinch valve configured to engage and deform the outlet in the closed condition.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2021
From: SCHIFF, DAVID R.; WEST, SHARON D.
To: BRESSLERGROUP, INC.
Reel/Frame 056104/0073 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2021
From: BRESSLERGROUP, INC.
To: FRESENIUS KABI DEUTSCHLAND GMBH
Reel/Frame 056104/0099 →
Cited By (2)
US 12,297,825 US 12,357,750